The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of pretreatment CA19-9 with survival after 3-fraction SBRT for locally advanced pancreatic cancer: Results from a phase I dose-escalation trial.
 
Marsha Reyngold
Research Funding - Varian Medical Systems
 
Sana Karam
Research Funding - AstraZeneca; Roche Belgium
 
Carla Hajj
No Relationships to Disclose
 
Abraham Jing-Ching Wu
Stock and Other Ownership Interests - Simphotek
Consulting or Advisory Role - AstraZeneca; MORE Health
Research Funding - CivaTech Oncology
Travel, Accommodations, Expenses - Alpha Tau; CivaTech Oncology
 
Paul Bernard Romesser
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - EMD Serono
Research Funding - EMD Serono
Travel, Accommodations, Expenses - Elekta
 
John J Cuaron
No Relationships to Disclose
 
Ellen Yorke
No Relationships to Disclose
 
Tracey E. Schefter
No Relationships to Disclose
 
Bernard Jones
Research Funding - Varian Medical Systems
 
Yevgeniy Vinogradskiy
No Relationships to Disclose
 
Christopher H. Crane
Stock and Other Ownership Interests - Oncternal Therapeutics
Honoraria - Elekta
Consulting or Advisory Role - TriSalus Life Sciences
Research Funding - Elekta (Inst)
 
Karyn A. Goodman
Consulting or Advisory Role - Novartis; Philips Healthcare; RenovoRx; Roche/Genentech